SUPRAFLEX CRUZ NEVO
Sirolimus-eluting cobalt chromium coronary stent system. SUPRAFLEX CRUZ NEVO combines…
Long term follow-up after ultrathin vs 2nd generation DES: review and metanalysis of randomized control trials
What is the benefit of ultrathin strut on long term TLF, a composite of cardiac death, Myocardial Infarct (MI), or clinically driven target lesion revascularization (CD-TLR) ?
Here is an intriguing review and metanalysis of randomized control trial comparing ultrathin vs 2nd generation DES.
At a mean follow-up of 2.5 years, ultrathin-strut DES reduced the risk of TLF, driven by less CD-TLR compared with conventional 2nd-generation thin-strut DES, with similar risks of MI, ST, cardiac death, and all-cause mortality.